USPTO serial 98978764
HORMOMETER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 25, 2026
- Examiner
- KRUSSMAN, IAN GEORGE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HORMOMETER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Montréal, QC, CA
Montréal, QC, CA
Montréal, QC, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rajesh Fotedar
Rajesh Fotedar COGNITION IP PC50 CALIFORNIA ST., SUITE 1500SAN FRANCISCO, CA 94105United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software application for analysis of saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Downloadable mobile software application for analysis of saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Downloadable software application for presentation of data from analysis of saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Downloadable mobile software application for presentation of data from analysis of saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Downloadable software application for analysis of hormone levels, namely, progesterone, cortisol, estradiol detected in saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Downloadable software application for presentation of data from analysis of hormone levels, namely, progesterone, cortisol, estradiol detected in saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Downloadable mobile software application for presentation of data from analysis of hormone levels, namely, progesterone, cortisol, estradiol detected in saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Wireless communication devices for wireless transmission of medical data and information; Wireless communication devices for wireless transmission of medical data and information, namely, device for transmitting data collected from a cartridge with a sample of saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at home; Wireless communication devices for transmitting data collected from a cartridge with a sample of saliva and measuring hormones present in the sample of saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at home; Wireless communication devices for transmitting data collected from a cartridge with a sample of saliva and measuring hormones, namely, progesterone, cortisol, estradiol present in the sample of saliva, namely, personally collected saliva, saliva collected in a non-clinical setting, saliva collected at-home; Downloadable software application for analysis of a collected sample of saliva; Downloadable mobile software application for analysis of a collected sample of saliva; Downloadable software application for analysis of a collected sample of bodily fluid(s); Downloadable mobile software application for analysis of a collected sample of bodily fluid(s); Downloadable software application for analysis of bodily fluid(s), namely, personally collected bodily fluid(s), bodily fluid(s) collected in a non-clinical setting, bodily fluid(s) collected at-home; Downloadable mobile software application for analysis of bodily fluid(s), namely, personally collected bodily fluid(s), bodily fluid(s) collected in a non-clinical setting, bodily fluid(s) collected at-home; Downloadable software application for analysis of hormone levels detected in a collected sample of saliva; Downloadable mobile software application for analysis of hormone levels detected in a collected sample of saliva; Downloadable software application for analysis of hormone levels detected in a collected sample of bodily fluid(s); Downloadable mobile software application for analysis of hormone levels detected in a collected sample of bodily fluid(s); Downloadable software application for presentation of data from analysis of hormone levels in a collected sample of saliva; Downloadable mobile software application for presentation of data from analysis of hormone levels in a collected sample of saliva; Downloadable software application for presentation of data from analysis of hormone levels in a collected sample of bodily fluid(s); Downloadable mobile software application for presentation of data from analysis of hormone levels in a collected sample of bodily fluid(s); Wireless communication devices for wireless transmission of medical data and information, namely, device for transmitting data from a cartridge with a sample of saliva; Wireless communication devices for wireless transmission of medical data and information, namely, device for transmitting data from a cartridge with a sample of a bodily fluid(s); Wireless communication devices for wireless transmission of medical data and information, namely, device for transmitting data from a cartridge with a sample of bodily fluid(s), namely, personally collected bodily fluid(s), bodily fluid(s) collected in a nonclinical setting, bodily fluid(s) collected at-home; Wireless communication devices for transmitting data from a cartridge with a sample of saliva and measuring hormones present in the sample of saliva; Wireless communication devices for transmitting data from a cartridge with a sample of saliva and measuring hormones present in the sample of bodily fluid(s) | ACTIVE | Feb 18, 2025 |
| 010 | Medical device for collecting saliva samples; Cartridge for collection of saliva for use with medical devices for collecting saliva samples; Cartridge for collection of saliva for use with medical devices for collecting saliva samples, namely, personal collection of saliva, collection of saliva in a non-clinical setting, at-home collection of saliva; medical device for collecting bodily fluid(s) samples; Cartridge for collection of bodily fluid(s) for use with medical devices for collecting bodily fluid samples; Cartridge for collection of bodily fluid(s) for use with medical devices for collecting bodily fluid samples, namely, personal collection of bodily fluid(s), collection of bodily fluid(s), in a non-clinical setting, at-home collection of bodily fluid(s) | ACTIVE | Jan 8, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Eli Science Inc.
- Other trademarks owned by Eli Science Inc.
- Other trademarks owned by Eli Science Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named HORMOMETER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 25, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 5, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 5, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 5, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 5, 2026 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| May 17, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 28, 2025 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Feb 27, 2025 | IUAF | USE AMENDMENT FILED | — |
| Feb 27, 2025 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Feb 27, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 7, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 7, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 6, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 6, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 6, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 11, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 11, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 25, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2023 | NWAP | NEW APPLICATION ENTERED | — |